Akeega FC Tablets
PDF Leaflet Revision Date: 26 August 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment for male adults with metastatic castration-resistant prostate cancer (mCRPC) with BRCA gene alterations.
Dosage (summary)
200 mg niraparib/1000 mg abiraterone acetate daily on an empty stomach.
Special Populations
- Elderly
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Not for use in women; potential for fetal harm; handle with gloves.
Key Drug Interactions
- Strong CYP3A4 inducers
- CYP2D6 substrates
- CYP2C8 substrates
Contraindications
- Hypersensitivity to components
- Moderate to severe hepatic impairment
- Women
Common side effects
- Anaemia
- Hypertension
- Thrombocytopenia
- Nausea
- Fatigue
Counselling Points
- Take on an empty stomach
- Monitor blood pressure
- Report signs of infection
Serious warnings
- Haematologic adverse reactions
- Hepatotoxicity
- Cardiovascular events
Important Disclaimer
The Akeega FC Tablets professional information leaflet below is the property of Janssen Pharmaceutica and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
